Name: ELI LILLY & CO (LLY) Stock
Brand: ELI LILLY & CO
Rating: 8 (3 reviews)

LLY Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Chartmill

ELI LILLY & CO (NYSE:LLY) Offers a High-Quality Dividend Backed by Strong Profitability and Growth

14 days ago - By: Chartmill - Mentions: RL GILD INCY DE ...

Top S&P500 movers in Friday's session

8 hours ago - By: Benzinga

New Eli Lilly Results Suggest Major Delay To Chemotherapy For Breast Cancer Patients

10 hours ago - By: Stocktwits

Eli Lilly Unveils New Data Showing Longer Survival With Breast Cancer Drug In Late-Stage Study

10 hours ago - By: Eli Lilly and Company

Updated data for Lilly's Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer

11 hours ago - By: Investor's Business Daily

Eli Lilly Rises, Again, After EMA Recommends Mounjaro For Children As Young As 10

11 hours ago - By: The Motley Fool - Mentions: BMY PFE

The Best Turnaround Stock to Invest $1,000 in Right Now

12 hours ago - By: Investor's Business Daily - Mentions: ORCL AVGO

Dow Jones, Russell 2000 Hit Highs, Buoyed By Fed; Oracle, Broadcom Weigh On Techs: Weekly Review

13 hours ago - By: Benzinga

FDA Weighs Rapid Review For Eli Lilly Obesity Pill As Novo Nordisk Nears Launch

15 hours ago - By: The Motley Fool

Think Eli Lilly Is Expensive? This Metric Says Otherwise.

16 hours ago - By: Wired

People Are Already Taking This Unapproved New Weight-Loss Drug

a day ago - By: Bloomberg - Mentions: ORCL DIS

Escalating AI Spend Sends Oracle Plummeting | Bloomberg Businessweek Daily 12/11/2025

a day ago - By: Bloomberg

Lilly’s Experimental Shot Cuts Body Weight by 23% in Study

a day ago - By: Bloomberg - Mentions: DIS ORCL

Disney, OpenAI Seal $1B Licensing Pact | Open Interest 12/11/2025

a day ago - By: CNBC - Mentions: ORCL V

Stocks making the biggest moves midday: Oracle, Vail Resorts, GE Vernova, Brinks, Ciena & more

2 days ago - By: Bloomberg - Mentions: DIS ORCL MA PYPL ...

New Lilly Shot Reduces Body Weight by 23% in Study

2 days ago - By: UPI

Senate to vote on competing healthcare bills - UPI.com

2 days ago - By: Stocktwits

Eli Lilly’s New Obesity Treatment Shows Weight Loss Up To 71.2 Lbs, Reduces Pain In Trial

2 days ago - By: CNBC - Mentions: ORCL V

Stocks making the biggest moves premarket: Oracle, Oxford Industries, Adobe, Gemini Space Station & more

2 days ago - By: CNBC

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

2 days ago - By: Investor's Business Daily

Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7%

2 days ago - By: CNBC

Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial

2 days ago - By: Eli Lilly and Company

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

2 days ago - By: Bloomberg

Lilly’s Experimental Shot Reduces Body Weight by 23% in Study

2 days ago - By: BusinessInsider - Mentions: GS NVO

LLY and NOVO: Goldman Sachs Weighs In on the Top Obesity Stocks to Watch in 2026

2 days ago - By: CNBC - Mentions: NVDA

The market likes what it heard from the Fed — plus, Lilly's new $6B manufacturing investment

2 days ago - By: Zacks Investment Research - Mentions: NVO VKTX GPCR

Can NVO Defend Its Obesity Lead as GLP-1 Competition Intensifies?

14 days ago - By: Chartmill - Mentions: CRL GILD BAX BBY ...

These S&P500 stocks are moving in today's session

14 days ago - By: Chartmill - Mentions: GILD INCY BBY ORCL ...

Gapping S&P500 stocks in Friday's session

19 days ago - By: Chartmill

Eli Lilly & Co (NYSE:LLY) Presents a Compelling Case for Growth at a Reasonable Price

19 days ago - By: Chartmill - Mentions: INTU AMD NVDA ESTC

ELI LILLY & CO (LLY) Stock News